ABBV vs HCA
By Alex · Tickerpine
AbbVie Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | HCA |
|---|---|---|
| Price | $253.35 | $391.68 |
| Market cap | $447.62B | $86.89B |
| P/E ratio | 123.6 | 13.5 |
| ROE | — | — |
| Profit margin | 5.79% | 8.89% |
| Revenue growth | 12.40% | 4.30% |
| Dividend yield | 2.73% | 0.80% |
| Beta | 0.31 | 1.13 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs HCA in plain English
- ABBV is the bigger company — about 5.2× the market cap of HCA.
- HCA is cheaper on earnings (P/E 13.5 vs 123.6).
- ABBV is growing revenue faster (12% vs 4%).
- ABBV has the higher dividend yield (2.73% vs 0.80%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.